🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Canada / NCT02410850
Recruiting Observational

Long Term Oral Appliance Therapy Effectiveness for Obstructive Sleep Apnea Syndrome

NCT02410850 · tracked via the Priya Life Science Canada tracker
Phase
Observational
Started
2018-04-01
Last updated
2024-01-23

Condition(s) studied

Obstructive Sleep Apnea

Investigational drug(s) / intervention(s)

Oral Appliance

Oral Appliance: Mandibular Advancement Splints

Study summary

Obstructive sleep apnea (OSA) is a highly prevalent breathing problem that occurs during sleep. OSA have been associated with the obesity epidemic in developing countries; additionally, high OSA prevalence rates are present in populations with cardiovascular and metabolic disorders. Two OSA treatments are currently available, oral appliance (OA) therapy and continuous positive airway pressure (CPAP). OAs are an underutilized non-surgical treatment and few studies have analyzed their long-term effectiveness for patients with OSA. The purpose of this study is to assess the long-term effectiveness of OA therapy in patients with OSA and to explore any changes on cardiovascular related morbidity and mortality related to this therapy.

Eligibility

Sex
ALL
Min age
18 Years
Max age
90 Years
Healthy volunteers
No
Inclusion Criteria: * Patients are currently prescribed Oral Appliance for their Obstructive Sleep Apnea Exclusion Criteria: * Patients under the age of 18 years. * Patients that do not understand the English language. * Patients that refuse to sign the informed consent for any reason.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
University of British Columbia Vancouver British Columbia Recruiting

More University of British Columbia trials in Canada

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT02410850 on ClinicalTrials.gov ↗ ← All trials in Canada